Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. - Wikidata - awgldk - TriplyDB

Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

http://www.wikidata.org/entity/Q47945739

about

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis Probiotics in inflammatory bowel diseases and associated conditions Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.Alternative medicines as emerging therapies for inflammatory bowel diseases.Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation.Probiotics: progress toward novel therapies for intestinal diseases.Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.Immune system stimulation by probiotic microorganisms.Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms.Effect of intestinal microbiota alteration on hepatic damage in rats with acute rejection after liver transplantation.Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.Gut microbiota and inflammation.Influence of dietary components on regulatory T cells.Alcoholic Liver Disease: A Mouse Model Reveals Protection by Lactobacillus fermentum Probiotics and the gut microbiota in intestinal health and disease Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view Induced and natural regulatory T cells in the development of inflammatory bowel disease.Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.Interaction with intestinal epithelial cells promotes an immunosuppressive phenotype in Lactobacillus casei.Probiotics and their derivatives as treatments for inflammatory bowel disease.Pros and cons of antibiotic therapy for pouchitis.Perceptions of medical sciences students towards probiotics Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease.Importance of disrupted intestinal barrier in inflammatory bowel diseases.Probiotic modulation of dendritic cells and T cell responses in the intestine.Etiology of pouchitis.The effects of commensal microbiota on immune cell subsets and inflammatory responses.Probiotics for the treatment of inflammatory bowel disease.Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects.Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.

P2860

Q24187707-7BDFC307-69D9-4A34-A13B-DF0F50DA7572 Q24234806-E49C0E8E-BF1C-4A56-B334-212F6FE42A30 Q27001546-8C1E945D-775B-4527-B18E-5256BBC8A193 Q27001712-A71D9126-C5A6-4375-BF91-36168C79C2B2 Q27002496-B4B47F23-199E-46F7-916F-2D684CFEE2BD Q27327276-C6733510-00EE-4AC5-8111-9BD3E3E56976 Q28254207-89374B97-9CB1-4A67-8237-E306F9598DF8 Q33406281-B16B1A9F-96B8-4E6A-89B9-C69D8B9739CC Q33427772-1BF18469-D210-4DA2-A469-59DBB78F76F1 Q34069427-97157E87-6058-4C8E-96B8-2B7AB6326BAB Q34170678-FE724159-0868-489A-ADD8-D245810FED77 Q34360325-370006AE-5B4B-4CA7-9C5A-A06CAE0EDAC9 Q34565839-B5BD760F-280D-41D0-9C55-8A10D688232E Q34637606-3E209D88-2B45-4F6E-BF32-982370CA6D27 Q34659496-AE7BA8E1-361B-4F55-A911-EFC687BA4287 Q34959432-793F5D3C-542A-42AE-9C73-DFE71D1A9160 Q35203307-B96285D1-0E3E-4F87-8CB1-139CC08FD0F9 Q35245299-BBD24A69-0D55-426E-939C-E957A1AEC4B4 Q35601294-DE9D344F-B79A-4C56-8594-EFA39742DC13 Q35670894-FD65AC54-73F0-4C08-BC4A-B92EE20DCA10 Q35747536-A4A52938-4C89-4140-9E81-CE90D79A90AD Q36534734-16FF642A-CE68-4037-8E01-1BF690A0647A Q36567134-B21CA39E-A36E-4CED-B890-B18CD99ACA87 Q36637753-10274FD0-5AC0-408E-A61F-4B539073901E Q36948341-6717D52B-6B2F-43C0-9326-5FEE39E41D74 Q37118477-179028DD-0D75-470B-AFF9-BD02BD4121FC Q37214848-2AAB5B5F-3A8A-49D9-B999-51D2C5CDFAE7 Q37288390-B3CB9582-3B27-433A-9A12-83DFC513F2E8 Q37448522-6CF5EC4B-32BF-4C99-8310-0E7B31A6C9B2 Q37611860-D506C118-18AB-424D-9A54-E7820807D7FF Q37658978-5D3F4909-C343-4B36-8946-335895A6F58E Q37729039-EE901541-78B1-4030-9F48-B4E78254517C Q37781315-D80A32AC-70E1-48B9-AD58-37D97379EB5E Q37915045-C0BE65C4-FD41-4106-9756-7C9163CC4276 Q37948714-6D3D6523-E1BE-40D4-8DD6-4775D86ACB33 Q37968293-A10059FE-19A1-4B65-84A8-A9CB56669CD7 Q38009716-D1714725-97E6-4227-9B42-FCEF58268B70 Q38268672-5CA26378-27F5-4EB0-81F2-D73009F0BB0D Q38732337-EA074F81-740A-44FF-8C87-1A88D90904E2 Q39007371-FBFE2B7F-9EE6-43AC-9435-7D14C7F63887

P2860

Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

http://www.wikidata.org/entity/Q47945739

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Probiotic administration in pa ...... n of mucosal regulatory cells.

@en

Probiotic administration in pa ...... n of mucosal regulatory cells.

@nl

type

label

Probiotic administration in pa ...... n of mucosal regulatory cells.

@en

Probiotic administration in pa ...... n of mucosal regulatory cells.

@nl

prefLabel

Probiotic administration in pa ...... n of mucosal regulatory cells.

@en

Probiotic administration in pa ...... n of mucosal regulatory cells.

@nl

P1433

Q47945739-4BDB30E3-78A2-4FDE-B75C-D1409CB478A1

P1476

Q47945739-C9A5D90D-6B88-4C31-B645-E63541497EE1

P2093

Q47945739-175D5743-B6C9-40AE-9A8A-6C7712BC5555

Q47945739-1AA3991F-A929-4D13-A92E-C1B6210A1857

Q47945739-6E8DBD7D-D72B-423F-98C3-F52E1A90E0F5

Q47945739-7A48BA47-1A78-4C61-B3FD-D301A2DE219B

Q47945739-8042F32F-5803-4261-86A1-72D267A8A5CB

Q47945739-8F5AA77B-8620-44EF-BC92-559D76DC84EF

Q47945739-BFF20AC7-8A2D-43B2-8171-1A53BBFFBBD9

Q47945739-D4A37F95-C885-45AE-92E8-63E4E7A96D1E

P2860

Q47945739-0713F561-FAAF-4CB1-8593-9D43F7C3E952

Q47945739-145B51F3-EF05-41DD-A4AA-41508C389FB7

Q47945739-1A831379-9FC2-41C6-B53B-B8FB77221CF1

Q47945739-234FBD4C-5721-4EB0-A057-FA50F0EAD7E3

Q47945739-2ACAB9E9-42A3-48B5-840B-F256645163A6

Q47945739-3B0FA341-FA77-4764-ABD1-38679577DF8F

Q47945739-3D7BAE11-B339-47F4-8A44-720024AAB508

Q47945739-40507FB1-64C9-4196-BE5E-0BE3EB18BACA

Q47945739-4F5E4C49-88AB-4F47-8D48-C206B7A2E5BF

Q47945739-5E5E7E65-4D97-4315-B0B6-140B79933F5B

P304

Q47945739-072C8D09-9DD7-4D5B-877D-71A9BC3033B2

P31

Q47945739-84E660EE-0DC1-43A9-BAE8-9A56645C3262

P356

Q47945739-88F6F97B-E36D-4535-B0F5-0E08E695B900

P433

Q47945739-BC37F961-C851-4421-821B-7E25B2C62B83

P478

Q47945739-FF90CC23-E28C-4485-8214-A6299F0F0179

P577

Q47945739-14609241-4371-41FC-87CA-A4DB8BC7AA23

P5875

Q47945739-ADEDB307-8C51-4ED2-85AB-808F9F3E9367

P698

Q47945739-634EB277-F012-4EB1-AF5D-396B46BE1CD3

P921

Q47945739-8034470D-65A8-4D65-8490-3FD5B8351E79

Q47945739-D8068C1B-0AA5-4550-8D3E-92A215FD82E3

P356

P1433

Inflammatory Bowel Diseases

P1476

Probiotic administration in pa ...... n of mucosal regulatory cells.

@en

P2093

AnnaRita Vestri

http://www.w3.org/2001/XMLSchema#string

Annamaria Pronio

http://www.w3.org/2001/XMLSchema#string

Chiara Montesani

http://www.w3.org/2001/XMLSchema#string

Cinzia Butteroni

http://www.w3.org/2001/XMLSchema#string

Domenico Vitolo

http://www.w3.org/2001/XMLSchema#string

Gloria Mumolo

http://www.w3.org/2001/XMLSchema#string

Monica Boirivant

http://www.w3.org/2001/XMLSchema#string

Simona Vecchione

http://www.w3.org/2001/XMLSchema#string

P2860

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

An essential role for Scurfin in CD4+CD25+ T regulatory cells

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses.

The immunological and genetic basis of inflammatory bowel disease.

Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin.

P304

662-668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.20369

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5612204

http://www.w3.org/2001/XMLSchema#string

P698

18240282

http://www.w3.org/2001/XMLSchema#string

P921